Evaluation of presepsin as a diagnostic tool in newborns with risk of early-onset neonatal sepsis
ObjectivesTo evaluate the efficacy of presepsin (P-SEP) as a potential biomarker of early-onset neonatal sepsis (EOS) and compare it to other routinely used markers of inflammation. To establish the cut-off values of P-SEP for EOS.Study design184 newborns were prospectively recruited between January...
Saved in:
Main Authors: | Iva Pospisilova (Author), Helena L. Brodska (Author), Marketa Bloomfield (Author), Klara Borecka (Author), Jan Janota (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack
by: Marketa Bloomfield, et al.
Published: (2020) -
Cord blood presepsin as a predictor of early-onset neonatal sepsis in term and preterm newborns
by: Francesca Priolo, et al.
Published: (2023) -
Endothelial Microvesicles and Soluble Markers of Endothelial Injury in Critically Ill Newborns
by: Veronika Vítková, et al.
Published: (2018) -
Presepsin as a sepsis biomarker
by: K. A. Trunova
Published: (2018) -
The Relationship between Physical Activity and Academic Achievement of University Students
by: Ondřej Machek, et al.
Published: (2019)